Modulating the p53-MDM2 pathway
EXCLI Journal · 22.11.2024 · 23 · 1397-1439
DOI: 10.17179/excli2024-7791 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift EXCLI Journal, online erschienen am 22.11.2024. Verfasst von Iman Ramli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Biochemistry, Faculté des Sciences de la Nature et de la Vie, Université Constantine 1 Frères Mentouri, 25000 Constantine, Alge…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The p53-MDM2 pathway plays a crucial role regulating tumor suppression and is a focal point of cancer research. This literature review delves into the complex interplay between the tumor suppressor protein p53 and its main regulator MDM2, highlighting their interaction and implications in cancer development and progression. The review compiles and summarizes the existing understanding of the biology and regulation of p53 and MDM2, emphasizing their roles in various cellular processes, including cell cycle regulation, DNA repair, apoptosis, and metabolism. It also discusses the disruption of the p53-MDM2 interaction in different cancer types and its impact on tumor progression and therapeutic resistance. Recent studies have highlighted natural products as promising avenues for targeting the p53-MDM2 pathway. This review categorizes these natural compounds into three groups based on their mechanisms: those that inhibit MDM2 expression or stability, those that prevent p53-MDM2 binding, and those that stabilize p53 by inhibiting MDM2’s E3 ligase activity. Detailed mechanisms of action, structural aspects, and potential therapeutic applications of various natural products, including polyphenols, terpenoids, and alkaloids, are presented. Despite significant advances in understanding the p53-MDM2 interaction and the identification of natural products capable of modulating this pathway, further research is necessary to evaluate the clinical efficacy, toxicity, and bioavailability of these compounds. The promising role of natural products in cancer therapy underscores the importance of ongoing investigation and development of these agents as potential treatments for cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Applied Biochemistry, Faculté des Sciences de la Nature et de la Vie, Université Constantine 1 Frères Mentouri, 25000 Constantine, Algeria.
- Unité de Valorisation des Ressources Naturelles, Molécules Bioactives et Analyses Physicochimiques et Biologiques, Université Constantine 1 Frères Mentouri, 25000 Constantine, Algeria.
- Département Science de la Nature et de la Vie, Faculté des Sciences Exactes et Sciencede la Nature et de la Vie, Université Mohammed Boudiaf-Oum El-Bouaghi, 04000 Oum El-Bouaghi, Algeria.
- Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43B, 07100 Sassari, Italy.
- Department of Microbiology, Faculty of Biological Sciences, Abia State University, Uturu, Nigeria.
- Covenant Applied Informatics Communication African Centre for Excellence (CApIC-ACE), Covenant University, Ota, Ogun State, Nigeria.
Zitieren
APA
Ramli, I., Cheriet, T., Posadino, A. M., Giordo, R., Fenu, G., Chukwuemeka Nwachukwu, K., Adebayo Oyewole, O., Oluwaseun Adetunji, C., Calina, D., Sharifi-Rad, J., & Pintus, G. (2024). Modulating the p53-MDM2 pathway. EXCLI Journal, 23, 1397-1439. https://doi.org/10.17179/excli2024-7791
Vancouver
Ramli I, Cheriet T, Posadino AM, Giordo R, Fenu G, Chukwuemeka Nwachukwu K, et al. Modulating the p53-MDM2 pathway. EXCLI Journal. 2024;23:1397-1439. doi:10.17179/excli2024-7791
BibTeX
@article{Ramli2024,
author = {Ramli, Iman and Cheriet, Thamere and Posadino, Anna Maria and Giordo, Roberta and Fenu, Grazia and Chukwuemeka Nwachukwu, Kingsley and Adebayo Oyewole, Oluwafemi and Oluwaseun Adetunji, Charles and Calina, Daniela and Sharifi-Rad, Javad and Pintus, Gianfranco},
title = {Modulating the p53-MDM2 pathway},
journal = {EXCLI Journal},
year = {2024},
volume = {23},
pages = {1397--1439},
doi = {10.17179/excli2024-7791}
}
EUVIMED